Last reviewed · How we verify
Clinical-judged midazolam administration
Clinical-judged midazolam administration is a Benzodiazepine Small molecule drug developed by Chang Gung Memorial Hospital. It is currently FDA-approved for Procedural sedation and anxiolysis, Preoperative anxiolysis, Induction of general anesthesia.
Midazolam is a benzodiazepine that enhances inhibitory GABAergic neurotransmission in the central nervous system to produce sedation, anxiolysis, and amnesia.
Midazolam is a benzodiazepine that enhances inhibitory GABAergic neurotransmission in the central nervous system to produce sedation, anxiolysis, and amnesia. Used for Procedural sedation and anxiolysis, Preoperative anxiolysis, Induction of general anesthesia.
At a glance
| Generic name | Clinical-judged midazolam administration |
|---|---|
| Sponsor | Chang Gung Memorial Hospital |
| Drug class | Benzodiazepine |
| Target | GABA-A receptor |
| Modality | Small molecule |
| Therapeutic area | Anesthesia/Sedation |
| Phase | FDA-approved |
Mechanism of action
Midazolam binds to benzodiazepine receptors on GABA-A channels, increasing chloride ion influx and hyperpolarizing neuronal membranes. This potentiates the inhibitory effects of GABA, resulting in dose-dependent central nervous system depression. Clinical-judged administration refers to individualized dosing based on patient response and clinical assessment rather than fixed protocols.
Approved indications
- Procedural sedation and anxiolysis
- Preoperative anxiolysis
- Induction of general anesthesia
- Acute agitation and anxiety
Common side effects
- Respiratory depression
- Hypotension
- Oversedation
- Paradoxical reaction (agitation)
- Amnesia
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Clinical-judged midazolam administration CI brief — competitive landscape report
- Clinical-judged midazolam administration updates RSS · CI watch RSS
- Chang Gung Memorial Hospital portfolio CI
Frequently asked questions about Clinical-judged midazolam administration
What is Clinical-judged midazolam administration?
How does Clinical-judged midazolam administration work?
What is Clinical-judged midazolam administration used for?
Who makes Clinical-judged midazolam administration?
What drug class is Clinical-judged midazolam administration in?
What development phase is Clinical-judged midazolam administration in?
What are the side effects of Clinical-judged midazolam administration?
What does Clinical-judged midazolam administration target?
Related
- Drug class: All Benzodiazepine drugs
- Target: All drugs targeting GABA-A receptor
- Manufacturer: Chang Gung Memorial Hospital — full pipeline
- Therapeutic area: All drugs in Anesthesia/Sedation
- Indication: Drugs for Procedural sedation and anxiolysis
- Indication: Drugs for Preoperative anxiolysis
- Indication: Drugs for Induction of general anesthesia
- Compare: Clinical-judged midazolam administration vs similar drugs
- Pricing: Clinical-judged midazolam administration cost, discount & access